Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $4.00 Average Target Price from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been assigned an average recommendation of “Hold” from the four brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $4.00.

BIOX has been the topic of a number of recent analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Friday, March 27th. Wall Street Zen downgraded Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research report on Saturday, April 4th. Finally, Canaccord Genuity Group lowered their price target on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research report on Friday, January 2nd.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of institutional investors have recently bought and sold shares of the business. Invesco Ltd. acquired a new position in Bioceres Crop Solutions during the fourth quarter worth approximately $45,000. Ardsley Advisory Partners LP grew its position in shares of Bioceres Crop Solutions by 691.7% in the fourth quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock valued at $622,000 after purchasing an additional 415,000 shares during the last quarter. GAM Holding AG acquired a new position in shares of Bioceres Crop Solutions in the fourth quarter valued at approximately $655,000. State of Wisconsin Investment Board acquired a new position in shares of Bioceres Crop Solutions in the fourth quarter valued at approximately $247,000. Finally, Marshall Wace LLP grew its position in shares of Bioceres Crop Solutions by 180.0% in the fourth quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock valued at $780,000 after purchasing an additional 382,744 shares during the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Price Performance

NASDAQ:BIOX opened at $0.59 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.69 and a current ratio of 0.90. The stock’s 50-day simple moving average is $0.53 and its 200 day simple moving average is $1.12. The company has a market cap of $37.43 million, a P/E ratio of -0.16 and a beta of 0.53. Bioceres Crop Solutions has a 52-week low of $0.35 and a 52-week high of $5.18.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its earnings results on Friday, March 13th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). The company had revenue of $73.67 million during the quarter, compared to analyst estimates of $104.55 million. Bioceres Crop Solutions had a negative net margin of 82.83% and a negative return on equity of 22.43%. As a group, sell-side analysts forecast that Bioceres Crop Solutions will post -0.16 EPS for the current fiscal year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.